Journals / Bayburt Üniversitesi Fen Bilimleri Dergisi / 2022 / Cilt: 5 Sayı: 2

Molecular Docking Analysis on the Antiviral Effects of Curcumin on SARS-CoV-2

Kurkuminin SARS-CoV-2 Üzerindeki Antiviral Etkileri Üzerine Moleküler Kenetlenme Analizi

Sefa Çelik(İSTANBUL ÜNİVERSİTESİ, FEN FAKÜLTESİ)0000-0001-6216-1297
Ayşen Özel(İSTANBUL ÜNİVERSİTESİ, FEN FAKÜLTESİ)0000-0002-8680-8830
Sevim Akyüz(İSTANBUL KÜLTÜR ÜNİVERSİTESİ, FEN-EDEBİYAT FAKÜLTESİ)0000-0003-3313-6927
Pages
223–228
Publication Date
2022-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The findings suggested that curcumin could be a useful therapeutic agent for COVID-19 treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The structural preferences of curcumin (C21H20O6) molecule were analyzed by MMFF method using Spartan06 program and the most stable geometry was determined.
📊
Key Findings & Data:To evaluate the effects of curcumin on SARS-CoV-2, the molecular docking studies have been done on the spike glycoprotein and the apo/holo forms of the SARS-CoV-2 major protease enzyme (Mpro).
💡
Conclusion & Impact:The findings suggested that curcumin could be a useful therapeutic agent for COVID-19 treatment.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · Kurkumin · Antienflamatuvar

Abstract

The structural preferences of curcumin (C21H20O6) molecule were analyzed by MMFF method using Spartan06 program and the most stable geometry was determined. To evaluate the effects of curcumin on SARS-CoV-2, the molecular docking studies have been done on the spike glycoprotein and the apo/holo forms of the SARS-CoV-2 major protease enzyme (Mpro). The binding affinities and binding modes of curcumin targeted to the SARS-CoV-2 proteins were determined. It was discovered that curcumin had binding affinities of -7.3, -5.7, and -7.6 kcal/mol to the apo and holo forms of the major protease enzyme (Mpro) and spike glycoprotein, respectively. The findings suggested that curcumin could be a useful therapeutic agent for COVID-19 treatment.

Özet

Kurkumin (C21H20O6) molekülünün yapısal tercihleri Spartan06 programı kullanılarak MMFF yöntemi ile analiz edilmiş ve en kararlı geometri belirlenmiştir. Kurkuminin SARS-CoV-2 üzerindeki etkilerini değerlendirmek için, SARS-CoV-2 ana proteaz enziminin (Mpro) apo/holo formları ve spike glikoprotein ile moleküler kenetlenme çalışmaları yapılmıştır. SARS-CoV-2 proteinlerini hedefleyen kurkuminin bağlanma afiniteleri ve bağlanma modları belirlenmiştir. Kurkuminin ana proteaz enziminin (Mpro) apo ve holo formlarına ve spike glikoproteine bağlanma afiniteleri sırasıyla -7.3, -5.7 ve -7.6 kcal/mol olarak bulunmuştur. Sonuçlar, kurkuminin COVID-19 tedavisi için potansiyel bir terapötik ajan olabileceğini göstermiştir.

🔖

Cite This Article

Demirag, A. D., Çelik, S., Özel, A., Akyüz, S. (2022). Molecular Docking Analysis on the Antiviral Effects of Curcumin on SARS-CoV-2. Bayburt Üniversitesi Fen Bilimleri Dergisi, Cilt: 5 Sayı: 2, 223–228. https://doi.org/10.55117/bufbd.1138678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (21)

  1. H. Gopinath and K. Karthikeyan, “Turmeric: A condiment, cosmetic and cure,” Indian Journal of Dermatology, Venereology and Leprology, vol. 84, no. 1, pp. 16, 2018.
  2. S. Hewlings and D. Kalman, “Curcumin: A Review of Its’ Effects on Human Health,” Foods, vol. 6, no. 10, pp. 92, 2017.
  3. J. Tabeshpour, M. Hashemzaei, and A. Sahebkar, “The regulatory role of curcumin on platelet functions,” Journal of Cellular Biochemistry, vol. 119, no. 11, pp. 8713–8722, 2018.
  4. A. Ali and A. C. Banerjea, “Curcumin inhibits HIV-1 by promoting Tat protein degradation,” Scientific Reports, vol. 6, no. 1, 2016.
  5. N. Zhang, H. Li, J. Jia, and M. He, “Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse,” Cellular Immunology, vol. 298, no. 1–2, pp. 88– 95, 2015.
  6. M. S. Karimian, M. Pirro, M. Majeed, and A. Sahebkar, “Curcumin as a natural regulator of monocyte chemoattractant protein-1,” Cytokine & Growth Factor Reviews, vol. 33, pp. 55–63, 2017.
  7. F. Zahedipour et al., “Potential effects of curcumin in the treatment of COVID ‐19 infection,” Phytotherapy Research, 2020.
  8. H. Noor, A. Ikram, T. Rathinavel, S. Kumarasamy, M. Nasir Iqbal, and Z. Bashir, “Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 – a computational modeling,” Journal of Biomolecular Structure and Dynamics, pp. 1–16, 2021.
  9. R. Jäger, R. P. Lowery, A. V. Calvanese, J. M. Joy, M. Purpura, and J. M. Wilson, “Comparative absorptionof curcumin formulations,” Nutrition Journal, vol. 13, no. 1, 2014.
  10. L. Sun et al., “Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling,” PLoS ONE, vol. 7, no. 2, pp. e30802, 2012.
  11. J. W. Schoggins and C. M. Rice, “Interferon-stimulated genes and their antiviral effector functions,” Current Opinion in Virology, vol. 1, no. 6, pp. 519–525, 2011.
  12. D. Ting et al., “Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin,” ACS Applied Nano Materials, vol. 1, no. 10, pp. 5451–5459, 2018.
  13. Y. Imai et al., “Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury,” Cell, vol. 133, no. 2, pp. 235–249, 2008.
  14. S. Rong et al., “Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity,” Phytomedicine, vol. 19, no. 6, pp. 545–550, 2012.
  15. M. Head-Gordon and et al. et al., “Advances in Methods and Algorithms in a Modern Quantum Chemistry Program Package,” ChemInform, vol. 37, no. 39, 2006.
  16. T. A. Halgren, “Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94,” Journal of Computational Chemistry, vol. 17, no. 5–6, pp. 553–586, 1996.
  17. A. Jurcik et al., “CAVER Analyst 2.0: analysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories,” Bioinformatics, vol. 34, no. 20, pp. 3586–3588, 2018.
  18. O. Trott and A. J. Olson, “AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading,” Journal of Computational Chemistry, vol. 31, no. 2, 2009.
  19. B. Zhang, Y. Zhao, Z. Jin, X. Liu, H. Yang, and Z. Rao, “The crystal structure of COVID-19 main protease in apo form,” 2020.
  20. V. Nath, A. Rohini, and V. Kumar, “Identification of Mpro inhibitors of SARS-CoV-2 using structure based computational drug repurposing,” Biocatalysis and Agricultural Biotechnology, vol. 37, pp. 102178, 2021.
  21. A. C. Walls, Y.-J. Park, M. A. Tortorici, A. Wall, A. T. McGuire, and D. Veesler, “Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein,” Cell, vol. 183, no. 6, pp. 1735, 2020.